Hassan H J, Casalbore P, De Laurenzi A, Petti N, Sinibaldi L, Orlando M
Haemostasis. 1984;14(3):244-8. doi: 10.1159/000215064.
A case of factor VII deficiency in a 52-year-old woman who developed central nervous system hemorrhage is here reported. Screening coagulation tests were all normal except for prothrombin time, normotest and thrombotest. Specific assays of vitamin K-dependent factors revealed that factor VII activity was reduced (11 U/dl). The studies of the family demonstrated that 2 sisters out of 4 were heterozygous for the defect. The activity of factor VII in the offspring, classified as obligatory carriers, ranged between 62 and 78 U/dl, the antigen between 55 and 75 U/dl. The wide variability of factor VII in normal people and the possible compensative effect of normal alleles in carriers do not allow to define the variant, namely if the patient is a CRMR homozygote or a CRMR/CRM-double heterozygote.
本文报告了一例52岁女性发生中枢神经系统出血的凝血因子VII缺乏症病例。除凝血酶原时间、正常凝血酶原时间和凝血酶试验外,筛查凝血试验均正常。维生素K依赖因子的特异性检测显示,凝血因子VII活性降低(11 U/dl)。家系研究表明,4个姐妹中有2个为该缺陷的杂合子。归类为必然携带者的后代中,凝血因子VII活性在62至78 U/dl之间,抗原在55至75 U/dl之间。正常人群中凝血因子VII的广泛变异性以及携带者中正常等位基因可能的补偿作用,使得无法确定该变异型,即患者是CRMR纯合子还是CRMR/CRM双杂合子。